Molecular Targeted Therapy
"Molecular Targeted Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Treatments with drugs which interact with or block synthesis of specific cellular components characteristic of the individual's disease in order to stop or interrupt the specific biochemical dysfunction involved in progression of the disease.
| Descriptor ID |
D058990
|
| MeSH Number(s) |
E02.319.574
|
| Concept/Terms |
Molecular Targeted Therapy- Molecular Targeted Therapy
- Molecular Targeted Therapies
- Targeted Therapies, Molecular
- Targeted Therapy, Molecular
- Therapies, Molecular Targeted
- Therapy, Molecular Targeted
- Targeted Molecular Therapy
- Molecular Therapies, Targeted
- Molecular Therapy, Targeted
- Targeted Molecular Therapies
- Therapies, Targeted Molecular
- Therapy, Targeted Molecular
|
Below are MeSH descriptors whose meaning is more general than "Molecular Targeted Therapy".
Below are MeSH descriptors whose meaning is more specific than "Molecular Targeted Therapy".
This graph shows the total number of publications written about "Molecular Targeted Therapy" by people in this website by year, and whether "Molecular Targeted Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 5 | 6 | 11 |
| 2012 | 7 | 11 | 18 |
| 2013 | 7 | 5 | 12 |
| 2014 | 7 | 14 | 21 |
| 2015 | 26 | 15 | 41 |
| 2016 | 10 | 17 | 27 |
| 2017 | 0 | 19 | 19 |
| 2018 | 7 | 17 | 24 |
| 2019 | 6 | 18 | 24 |
| 2020 | 4 | 13 | 17 |
| 2021 | 2 | 13 | 15 |
| 2022 | 1 | 2 | 3 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 11 | 12 |
| 2025 | 4 | 10 | 14 |
| 2026 | 2 | 9 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Molecular Targeted Therapy" by people in Profiles.
-
Intratumoral and intracranial hemorrhage associated with MAPK-pathway targeted therapy: a systematic review and mechanistic synthesis. J Neurooncol. 2026 Jul 15; 178(3).
-
Updates in Childhood Acute Lymphoblastic Leukemia. Hematol Oncol Clin North Am. 2026 06; 40(3):331-346.
-
Evolving Treatment Paradigms in Hormone Receptor-Positive, Human Epidermal Growth Factor 2-Negative Metastatic Breast Cancer. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e520518.
-
Incorporating ALL Biology into Treatment Decisions: Next Steps toward Targeted Therapy in Adult ALL. Blood Cancer Discov. 2026 05 05; 7(3):369-379.
-
Genetic characteristics and targeted treatments of primary bladder and urachal adenocarcinomas: a systematic review with pooled descriptive genomic analyses. Cancer Metastasis Rev. 2026 05 01; 45(2).
-
Non-coding RNAs as biomarkers and therapeutic targets in pancreatic cancer: Clinical implications and translational perspectives. Biomed Pharmacother. 2026 Jun; 199:119394.
-
Androgen receptor as a therapeutic target in endometrial cancer: a narrative review. Int J Gynecol Cancer. 2026 06; 36(6):104698.
-
Advanced Triple-Negative Breast Cancer: Emerging Therapies and a Changing Treatment Landscape. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e520506.
-
Less Is More, But Me-Too Should Not Be the Strategy for Lung Cancer Treatment in 2026. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e517100.
-
Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2026 Apr; 24(4).